[1]王　岩,张爱霞,王紫晖,等.高通量血液透析与联机血液透析滤过联合治疗慢性肾衰竭疗效观察[J].新乡医学院学报,2022,39(6):573-577.[doi:10.7683/xxyxyxb.2022.06.015]
　WANG Yan,ZHANG Aixia,WANG Zihui,et al.Curative effect of high-flux hemodialysis combined with online hemodiafiltration in the treatment of chronic renal failure[J].Journal of Xinxiang Medical University,2022,39(6):573-577.[doi:10.7683/xxyxyxb.2022.06.015]
点击复制

高通量血液透析与联机血液透析滤过联合治疗慢性肾衰竭疗效观察
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
39
期数:
2022年6
页码:
573-577
栏目:
临床研究
出版日期:
2022-06-05

文章信息/Info

Title:
Curative effect of high-flux hemodialysis combined with online hemodiafiltration in the treatment of chronic renal failure
作者:
王　岩; 张爱霞; 王紫晖; 王谦受
（洛阳市东方人民医院/河南科技大学第三附属医院血液净化科，河南　洛阳　471003）
Author(s):
WANG Yan; ZHANG Aixia; WANG Zihui; WANG Qianshou
(Department of Blood Purification,Luoyang Dongfang People′s Hospital,the Third Affiliated Hospital of Henan University of Science and Technology,Luoyang 471003,Henan Province,China)
关键词:
慢性肾衰竭; 高通量血液透析; 联机血液透析滤过
Keywords:
chronic renal failure; high-flux hemodialysis; online hemodiafiltration
分类号:
R459.5
DOI:
10.7683/xxyxyxb.2022.06.015
文献标志码:
A
摘要:
目的　比较高通量血液透析（HFHD）与联机血液透析滤过（OL-HDF）联合治疗慢性肾衰竭（CRF）的临床效果。方法　选择2018年10月至2019年10月洛阳市东方人民医院收治的90例CRF患者为研究对象，根据血液透析方法将患者分为观察组（n=49）和对照组（n=41）。对照组患者给予HFHD治疗，每周3次；观察组患者给予HFHD和OL-HDF联合治疗，每2周5次HFHD和1次OL-HDF。分别于治疗前及治疗3个月后检测2组患者血清中尿素、尿酸、β2-微球蛋白（β2-MG）和甲状旁腺激素（PTH）水平，并计算尿素清除指数（Kt/V）、标准蛋白分解代谢率（nPCR）和时间平均尿素浓度（TACurea）；分别于治疗前及治疗12个月后采用视觉模拟评分法（VAS）评估2组患者的皮肤瘙痒情况，并观察患者治疗12个月内并发症的发生情况。结果　治疗前2组患者血清中尿素、尿酸、PTH和β2-MG水平比较差异无统计学意义（P>0.05），2组患者治疗3个月后血清中尿素、尿酸、PTH和β2-MG水平显著低于治疗前（P<0.05）；治疗3个月后，2组患者血清中尿素、尿酸水平比较差异无统计学意义（P>0.05），但观察组患者血清中PTH、β2-MG水平显著低于对照组（P<0.05）。治疗3个月后,2组患者的Kt/V、nPCR和TACurea比较差异无统计学意义（P>0.05）。治疗前2组患者皮肤瘙痒VAS评分比较差异无统计学意义（P>0.05），2组患者治疗12个月后皮肤瘙痒VAS评分显著低于治疗前（P<0.05）；治疗12个月后，观察组患者皮肤瘙痒VAS评分显著低于对照组（P<0.05）。治疗前观察组和对照组患者并发症发生率分别为65.31%（32/49）、63.41%（26/41），治疗12个月后观察组和对照组患者并发症发生率分别为10.20%（5/49）、36.59%（15/41）。治疗前2组患者并发症发生率比较差异无统计学意义（χ2=0.035，P>0.05），2组患者治疗12个月后并发症发生率显著低于治疗前（χ2=31.654、5.902，P<0.05）；治疗12个月后，观察组患者并发症发生率显著低于对照组（χ2=8.988，P<0.05）。结论　与单独HFHD治疗相比，HFHD与OL-HDF联合治疗可以更有效地清除CRF患者血液中的PTH、β2-MG等中、大分子物质，减轻患者皮肤瘙痒症状，降低并发症发生率。
Abstract:
Objective　To compare the clinical curative effect of high-flux hemodialysis (HFHD) combined with online hemodiafiltration (OL-HDF) in the treatment of chronic renal failure (CRF).Methods　A total of 90 CRF patients admitted to Luoyang Dongfang People′s Hospital from October 2018 to October 2019 were selected as the research subjects,and the patients were divided into the observation group (n=49) and control group (n=41) according to the method of hemodialysis.The patients in the control group were treated with HFHD,three times a week.The patients in the observation group were given the combined treatment of HFHD and OL-HDF,five times of HFHD and one time of OL-HDF every two weeks.The levels of serum urea,uric acid,β2-microglobulin (β2-MG) and parathyroid hormone (PTH) of patients in the two groups were detected before treatment and after three months of treatment,and the urea clearance index (Kt/V),normalized protein catabolic rate (nPCR) and time-average concentration of urea (TACurea) were calculated.The skin pruritus of patients in the two groups was evaluated by visual analogue scale (VAS) before treatment and after 12 months of treatment.The incidence of complications within 12 months of treatment was observed.Results　There was no significant difference in serum urea,uric acid,PTH and β2-MG levels between the two groups before treatment (P>0.05).The levels of serum urea,uric acid,PTH and β2-MG of patients in the two groups after three months of treatment were significantly lower than those before treatment (P<0.05).After three months of treatment,there was no significant difference in serum urea and uric acid levels of patients between the two groups (P>0.05),but the serum PTH and β2-MG levels of patients in the observation group were significantly lower than those in the control group (P<0.05).There was no significant difference in Kt/V,nPCR and TACurea of patients between the two groups after three months of treatment (P>0.05).There was no significant difference in VAS score of skin pruritus between the two groups before treatment (P>0.05).The VAS score of skin pruritus of patients in the two groups after 12 months of treatment was significantly lower than that before treatment (P<0.05).After 12 months of treatment,the VAS score of skin pruritus of patients in the observation group was significantly lower than that in the control group (P<0.05).Before treatment,the incidence of complications of patients in the observation group and the control group was 65.31% (32/49) and 63.41%(26/41),respectively.After 12 months of treatment,the incidence of complications of patients in the observation group and the control group was 10.20%(5/49) and 36.59%(15/41),respectively.There was no significant difference in the incidence of complications of patients between the two groups before treatment (χ2=0.035,P>0.05).The incidence of complications of patients after 12 months of treatment was significantly lower than that before treatment in the two groups (χ2=31.654,5.902;P<0.05).After 12 months of treatment,the incidence of complications of patients in the observation group was significantly lower than that in the control group (χ2=8.988,P<0.05).Conclusion　Compared with HFHD alone,the combined treatment of HFHD and OL-HDF can more effectively remove PTH,β2-MG and other medium and macromolecular substances in blood of CRF patients,relieve the symptoms of skin pruritus,and reduce the incidence of complications.

参考文献/References:

［1］　OLSEN E,VAN GALEN G.Chronic renal failure:causes,clinical findings,treatments and prognosis［J］.Vet Clin North Am Equine Pract,2022,38(1):25-46.
［2］　GARCA TESTAL A,GARCA MASET R,FORNS FERRER V,et al.Cohort study with patients older than 80?years with stage 5 chronic kidney failure on hemodialysis vs conservative treatment:survival outcomes and use of healthcare resources［J］.Ther Apher Dial,2021,25(1):24-32.
［3］　CHENG W,LUO Y,WANG H,et al.Survival outcomes of hemoperfusion and hemodialysis versus hemodialysis in patients with end-stage renal disease:a systematic review and meta-analysis［J］. Blood Purif,2022,51(3):213-225.
［4］　THAMMATHIWAT T,TIRANATHANAGUL K,LIMJARIYAKUL M,et al.Super high-flux hemodialysis provides comparable effectiveness with high-volume postdilution online hemodiafiltration in removing protein-bound and middle-molecule uremic toxins:a prospective cross-over randomized controlled trial［J］.Ther Apher Dial,2021,25(1):73-81.
［5］　KIKUCHI K,HAMANO T,WADA A,et al.Predilution online hemodiafiltration is associated with improved survival compared with hemodialysis［J］.Kidney Int,2019,95(4):929-938.
［6］　中国中西医结合学会肾脏疾病专业委员会.慢性肾衰竭中西医结合诊疗指南［J］.中国中西医结合杂志，2015，35（9）：1029-1033.
PROFESSIONAL COMMITTEE OF RENAL DISEASES,CHINESE ASSOCIATION OF INTEGRATIVE MEDICINE.Guidelines for the diagnosis and treatment of chronic renal failure with integrated traditional Chinese and western medicine［J］.CJITWM,2015,35(9):1029-1033.
［7］　RAIKOU V D,KYRIAKI D.The association between intradialytic hypertension and metabolic disorders in end stage renal disease［J］. Int J Hypertens,2018,1(1):1-9.
［8］　NISHIZAWA Y,HOSODA Y,HORIMOTO A,et al.Fibroblast growth factor 23 (FGF23) level is associated with ultrafiltration rate in patients on hemodialysis［J］.Heart Vessels,2020,36(3):414-423.
［9］　BERGASA N V,JONES E A.Assessment of the visual analogue score in the evaluation of the pruritus of cholestasis［J］.J Clin Transl Hepatol,2017,5(3):203-207.
［10］　SHOSHTARI F S,BIRANVAND S,REZAEI L,et al.The impact of hemodialysis on retinal and choroidal thickness in patients with chronic renal failure［J］. Int Ophthalmol,2021,41(5):1763-1771.
［11］　汤晓静，陈楠，戎殳，等.高通量血液透析与常规血液透析联合血液透析滤过的临床疗效对比研究［J］.中国血液净化，2019，18（7）：486-490.
TANG X J,CHEN N,RONG S,et al.The comparison of clinical effects and outcome in patients with high-flux hemodialysis and those with low-flux hemodialysis combined with hemodiafiltration［J］.Chin J Blood Purif,2019,18(7):486-490.
［12］　LIU S X,LIU H,WANG Z H,et al.Effect of changing treatment to high-flux hemodialysis (HFHD) on mortality in patients with long-term low flux hemodialysis (LFHD):a propensity score matched cohort study［J］.BMC Nephrol,2020,21(1):485-491.
［13］　LI X,XU H,XIAO X C,et al.Prognostic effect of high-flux hemodialysis in patients with chronic kidney disease［J］. Braz J Med Biol Res,2016,49(1):e4708.
［14］　姜维.联机血液透析滤过联合血液灌流对终末期肾病患者血CTGF、NT-ProBNP水平的影响［J］.内科急危重症杂志，2017，23（5）：405-406.
JIANG W.Effects of online hemodiafiltration combined with hemoperfusion on serum CTGF and NT-ProBNP levels in patients with end-stage renal disease［J］.J Int Intens Med,2017,23(5):405-406.
［15］　杨莉.高通量血液透析与联机血液透析滤过清除溶质效果比较［J］.安徽医药，2008，12（6）：516-518.
YANG L.Comparison of the efficacy of removing solutes among on-line hemodiafiltration and high-flux hemodialysis［J］.Anhui Med Pharm J,2008,12(6):516-518.
［16］　吴戈青，崔英，陈燕春.HFHD联合HDF序贯用于维持性血液透析的价值研究［J］.重庆医学，2020，49（16）：2679-2682.
WU G Q,CUI Y,CHEN Y C.Study on the sequential application value of HFHD and HDF in maintenance hemodialysis［J］. Chongqing Med,2020,49(16):2679-2682.
［17］　肖艳美，张文贤，董小伟，等.不同透析治疗对终末期肾衰竭伴皮肤瘙痒患者钙磷代谢和PTH水平的影响［J］.医学临床研究，2018，35（1）：190-192.
XIAO Y M,ZHANG W X,DONG X W,et al.Effects of different dialysis treatments on calcium and phosphorus metabolism and PTH levels in patients with end-stage renal failure with pruritus［J］.J Clin Res,2018,35(1):190-192.
［18］　李娟，涂晓文，李燕妮.高通量血液透析治疗尿毒症患者皮肤瘙痒的效果分析［J］.北京医学，2020，42（2）：103-105.
LI J,TU X W,LI Y N.Analysis of the effect of high flux hemodialysis on skin pruritus in patients with uremia［J］.Beijing Med,2020,42(2):103-105.
［19］　BELMOUAZ M,DIOLEZ J,BAUWENS M,et al.Comparison of hemodialysis with medium cut-off dialyzer and on-line hemodiafiltration on the removal of small and middle-sized molecules［J］. Clin Nephrol,2018,89(1):50-56.
［20］　李丹妮，朱士彦，罗承志.慢性肾脏病合并心血管疾病患者血液透析治疗对微炎症因子及血管钙化的影响［J］.海南医学，2021，32（13）：1652-1654.
LI D N,ZHU S Y,LUO C Z.Effects of hemodialysis on microinflammatory factors and vascular calcification in patients with chronic kidney disease and cardiovascular disease［J］.Hainan Med,2021,32(13):1652-1654.
［21］　曹阳，曹晨，万小丹.血清PTH、Hcy、TPO-Ab与妊娠期高血压患者病情严重程度的关系［J］.中南医学科学杂志，2021，49（6）：725-727，744.
CAO Y,CAO C,WAN X D.The relationship between serum PTH,Hcy and TPO-Ab and the severity of hypertension in pregnancy［J］. Med Sci J Cent South China,2021,49(6):725-727,744.
［22］　熊敏.β2-微球蛋白与总胆红素联合检测在冠心病诊断中的应用［J］.医学理论与实践，2021，34（6）：901-903,919.
XIONG M.Application of combined detection of β2-microglobulin and total bilirubin in diagnosis of coronary heart disease［J］.J Med Theor Pract,2021,34(6):901-903,919.

相似文献/References:

[1]夏文宏,周慧霞.高通量血液透析、血液透析滤过和常规血液透析效果比较[J].新乡医学院学报,2015,32(05):422.
[2]李　佳,李庆超,路　华.高通量血液透析与低通量血液透析对重症肾衰竭患者肾功能及预后的影响[J].新乡医学院学报,2022,39(1):071.[doi:10.7683/xxyxyxb.2022.01.015]
　LI Jia,LI Qingchao,LU Hua.Effect of high flux hemodialysis and low flux hemodialysis on renal function and prognosis of patients with severe renal failure[J].Journal of Xinxiang Medical University,2022,39(6):071.[doi:10.7683/xxyxyxb.2022.01.015]
[3]马亚丽,陈宝平.百令胶囊联合α-酮酸片对非透析慢性肾衰竭患者微炎症状态及营养状况的影响[J].新乡医学院学报,2016,33(6):527.[doi:10.7683/xxyxyxb.2016.06.023]
　MA Ya-li,CHEN Bao-ping.Effect of Bailing capsule combined with α-keto acid tablets on micro-inflammation state and nutritional status of patients with non-dialysis chronic renal failure[J].Journal of Xinxiang Medical University,2016,33(6):527.[doi:10.7683/xxyxyxb.2016.06.023]
[4]朱海龙,王俊.黄芪注射液联合高通量血液透析对尿毒症患者肾功能和血清微RNA-155、白细胞介素-17、超敏C反应蛋白水平的影响[J].新乡医学院学报,2023,40(1):073.[doi:10.7683/xxyxyxb.2023.01.013]
　ZHU Hailong,WANG Jun.Effect of astragalus injection combined with high-flux hemodialysis on renal function and serum microRNA-155,interleukin-17 and hypersensitive C-reactive protein levels of patients with uremia[J].Journal of Xinxiang Medical University,2023,40(6):073.[doi:10.7683/xxyxyxb.2023.01.013]
[5]李会宁,黄智敏.高通量血液透析对老年终末期肾病患者氧化应激及微炎症状态的影响[J].新乡医学院学报,2023,40(11):1069.[doi:10.7683/xxyxyxb.2023.11.012]
　LI Huining,HUANG Zhimin.Effect of high-flux hemodialysis on oxidative stress and microinflammatory status in elderly patients with end-stage renal disease[J].Journal of Xinxiang Medical University,2023,40(6):1069.[doi:10.7683/xxyxyxb.2023.11.012]

更新日期/Last Update: 2022-06-05